Novartis Down Over 12%, On Pace for Record Percent Decrease — Data Talk
Novartis AG Sponsored ADR (NVS) is currently at $140.06, down $19.93 or 12.46%
--Would be lowest close since Jan. 5, 2026, when it closed at $137.91
--Would be largest percent decrease on record (Based on available data back to Dec. 24, 1996)
--Currently down two consecutive days; down 14.12% over this period
--Worst two day stretch on record (Based on available data back to Dec. 24, 1996)
--Down 7.89% month-to-date
--Up 1.59% year-to-date
--Down 16.94% from its all-time closing high of $168.62 on Feb. 27, 2026
--Up 9.38% from 52 weeks ago (Sept. 9, 2025), when it closed at $128.05
--Down 16.94% from its 52-week closing high of $168.62 on Feb. 27, 2026
--Up 14.99% from its 52-week closing low of $121.80 on Oct. 29, 2025
--Traded as low as $139.45; lowest intraday level since Jan. 6, 2026, when it hit $139.09
--Down 12.84% at today's intraday low; largest intraday percent decrease since March 16, 2020, when it fell as much as 13.1%
All data as of 9:37:10 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
September 08, 2026 09:54 ET (13:54 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy Before They Rise Further
2 Undervalued Stocks to Buy Before They Rebound
The 10 Best Dividend Stocks
12 Best Blue-Chip Stocks to Buy for the Long Term
